Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917

O. Dusek, A. Fajstova, A. Klimova, P. Svozilkova, T. Hrncir, M. Kverka, S. Coufal, J. Slemin, H. Tlaskalova-Hogenova, JV. Forrester, J. Heissigerova

. 2020 ; 10 (1) : . [pub] 20201225

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21026326

Grant support
NV17-31248A MZ0 CEP Register

Non-infectious uveitis is considered an autoimmune disease responsible for a significant burden of blindness in developed countries and recent studies have linked its pathogenesis to dysregulation of the gut microbiota. We tested the immunomodulatory properties of two probiotics, Escherichia coli Nissle 1917 (EcN) and E. coli O83:K24:H31 (EcO), in a model of experimental autoimmune uveitis (EAU). To determine the importance of bacterial viability and treatment timing, mice were orally treated with live or autoclaved bacteria in both preventive and therapeutic schedules. Disease severity was assessed by ophthalmoscopy and histology, immune phenotypes in mesenteric and cervical lymph nodes were analyzed by flow cytometry and the gut immune environment was analyzed by RT-PCR and/or gut tissue culture. EcN, but not EcO, protected against EAU but only as a live organism and only when administered before or at the time of disease induction. Successful prevention of EAU was accompanied by a decrease in IRBP-specific T cell response in the lymph nodes draining the site of immunization as early as 7 days after the immunization and eye-draining cervical lymph nodes when the eye inflammation became apparent. Furthermore, EcN promoted an anti-inflammatory response in Peyer's patches, increased gut antimicrobial peptide expression and decreased production of inducible nitric oxide synthase in macrophages. In summary, we show here that EcN controls inflammation in EAU and suggest that probiotics may have a role in regulating the gut-eye axis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026326
003      
CZ-PrNML
005      
20211026133003.0
007      
ta
008      
211013s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cells10010023 $2 doi
035    __
$a (PubMed)33375578
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dusek, Otakar $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
245    10
$a Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917 / $c O. Dusek, A. Fajstova, A. Klimova, P. Svozilkova, T. Hrncir, M. Kverka, S. Coufal, J. Slemin, H. Tlaskalova-Hogenova, JV. Forrester, J. Heissigerova
520    9_
$a Non-infectious uveitis is considered an autoimmune disease responsible for a significant burden of blindness in developed countries and recent studies have linked its pathogenesis to dysregulation of the gut microbiota. We tested the immunomodulatory properties of two probiotics, Escherichia coli Nissle 1917 (EcN) and E. coli O83:K24:H31 (EcO), in a model of experimental autoimmune uveitis (EAU). To determine the importance of bacterial viability and treatment timing, mice were orally treated with live or autoclaved bacteria in both preventive and therapeutic schedules. Disease severity was assessed by ophthalmoscopy and histology, immune phenotypes in mesenteric and cervical lymph nodes were analyzed by flow cytometry and the gut immune environment was analyzed by RT-PCR and/or gut tissue culture. EcN, but not EcO, protected against EAU but only as a live organism and only when administered before or at the time of disease induction. Successful prevention of EAU was accompanied by a decrease in IRBP-specific T cell response in the lymph nodes draining the site of immunization as early as 7 days after the immunization and eye-draining cervical lymph nodes when the eye inflammation became apparent. Furthermore, EcN promoted an anti-inflammatory response in Peyer's patches, increased gut antimicrobial peptide expression and decreased production of inducible nitric oxide synthase in macrophages. In summary, we show here that EcN controls inflammation in EAU and suggest that probiotics may have a role in regulating the gut-eye axis.
650    _2
$a zvířata $7 D000818
650    _2
$a autoimunitní nemoci $x terapie $7 D001327
650    _2
$a modely nemocí na zvířatech $7 D004195
650    12
$a Escherichia coli $7 D004926
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zánět $x terapie $7 D007249
650    _2
$a střevní sliznice $x patologie $7 D007413
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    12
$a probiotika $x aplikace a dávkování $x farmakologie $7 D019936
650    _2
$a uveitida $x terapie $7 D014605
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fajstova, Alena $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
700    1_
$a Klimova, Aneta $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Svozilkova, Petra $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Hrncir, Tomas $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 549 22 Novy Hradek, Czech Republic
700    1_
$a Kverka, Miloslav $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
700    1_
$a Coufal, Stepan $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
700    1_
$a Slemin, Johan $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
700    1_
$a Tlaskalova-Hogenova, Helena $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
700    1_
$a Forrester, John V $u Section of Immunology and Infection, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB24 3FX, UK $u Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia 6009, Australia $u Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia 6009, Australia
700    1_
$a Heissigerova, Jarmila $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
773    0_
$w MED00194911 $t Cells $x 2073-4409 $g Roč. 10, č. 1 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33375578 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133009 $b ABA008
999    __
$a ok $b bmc $g 1715141 $s 1146833
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 1 $e 20201225 $i 2073-4409 $m Cells $n Cells $x MED00194911
GRA    __
$a NV17-31248A $p MZ0
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Archiving options